17 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
as transparency laws regarding payments or other items of value provided to healthcare providers.
The U.S. federal Anti-Kickback Statute prohibits … transparency in product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement
F-3
EX-5.1
AUTL
Autolus Therapeutics plc
14 Apr 22
Shelf registration (foreign)
9:30pm
by the Prospectus (Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/1234), the Official Listing of Securities, Prospectus and Transparency (Amendment etc.) (EU
F-3
EX-5.1
AUTL
Autolus Therapeutics plc
6 Aug 21
Shelf registration (foreign)
2:30pm
(Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/1234), the Official Listing of Securities, Prospectus and Transparency (Amendment etc.) (EU Exit
6-K
EX-1
s0ta9ya4 zrl2wyg
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-5.1
mb29fqmzrp7cp 1tujd
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1
i8573d5 ob1e23kl
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1
jb10xbai63c8bjxl7yx
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
j7nsgvhtet9v7
23 Nov 18
Annual report (foreign)
12:00am
424B4
3wtlctrtp 9mwhuq
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
4kx4yo69g
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
2bxis5sjmz
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
ka3lxc
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
9g9 xkurabcdd
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next